$3.33
0.113.42%
At close: -
$3.07
-0.26-7.81%
After Hours: 6:42 AM EDT
Comments
Loading...
Elutia (NASDAQ:ELUT) Stock Quotes, Forecast and News Summary
Elutia Stock (NASDAQ: ELUT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Elutia (ELUT) stock?
You can purchase shares of Elutia (NASDAQ:ELUT) through any online brokerage.
Who are Elutia (ELUT) competitors?
Other companies in Elutia’s space includes: Renovaro (NASDAQ:RENB), Adaptimmune Therapeutics (NASDAQ:ADAP), Fate Therapeutics (NASDAQ:FATE), Kyverna Therapeutics (NASDAQ:KYTX) and TScan Therapeutics (NASDAQ:TCRX).
What is the forecast, or price target, for Elutia (ELUT) stock?
Elutia has a consensus price target of $10.00.
What is the current price for Elutia (ELUT)?
The stock price for Elutia (NASDAQ: ELUT) is $3.33 last updated February 26, 2025 at 4:00 PM EST.
Does Elutia (ELUT) pay a dividend?
There are no upcoming dividends for Elutia.
When is Elutia (NASDAQ:ELUT) reporting earnings?
Elutia’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Elutia (ELUT) going to split?
There is no upcoming split for Elutia.
What sector and industry does Elutia (ELUT) operate in?
Elutia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.